Digoxin-Inactivating Bacteria: Identification in Human Gut Flora
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Digoxin, the most widely used cardiac glycoside, undergoes significant metabolic conversion in many patients to cardioinactive metabolites in which the lactone ring is reduced. This appears to occur within the gastrointestinal tract. An attempt was made to isolate and identify the organisms capable of reducing digoxin from stool cultures obtained from human volunteers. Of hundreds of isolates studied, only Eubacterium lentum , a common anaerobe of the human colonic flora, converted digoxin to reduced derivatives. Such organisms were also isolated in high concentrations from the stools of individuals who did not excrete these metabolites when given digoxin in vivo. When the growth of E. lentum was stimulated by arginine, inactivation of digoxin was inhibited. Neither the presence of these organisms alone nor their concentration within the gut flora appeared to determine whether digoxin would be inactivated by this pathway in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“neither the presence nor the abundance of this species predicts digoxin reductions64–66. This discrepancy appears to be driven by strain-level variations in the E. lenta population67.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [64]
Citations
Cites
Human Fecal Flora: The Normal Flora of 20 Japanese-Hawaiians
Moore, W. E. C., & Holdeman, L. V. (1974) · Applied Microbiology · doi:10.1128/am.27.5.961-979.1974 · Cited by 1,144
Effect of diet on human fecal flora: comparison of Japanese and American diets
Finegold, S. M., Attebery, H. R., & Sutter, V. L. (1974) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/27.12.1456 · Cited by 518
Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy
Lindenbaum, J., Rund, D. G., Butler, V. P., Tse-Eng, D., & Saha, J. R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110013051403 · Cited by 423
Self-citationFecal microbial flora in Seventh Day Adventist populations and control subjects
Finegold, S., Sutter, V., Sugihara, P., Elder, H., Lehmann, S., & Phillips, R. (1977) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/30.11.1781 · Cited by 187
Fecal bacteriology of colonic polyp patients and control patients.
Finegold, S. M., Flora, D. J., Attebery, H. R., & Sutter, V. L. (1975) · PubMed · Cited by 137
Digoxin Metabolism in Patients
Peters, U. (1978) · Archives of Internal Medicine · doi:10.1001/archinte.1978.03630320018009 · Cited by 84
Unusually large digitalis requirements
Luchi, R. J., & Gruber, J. W. (1968) · The American Journal of Medicine · doi:10.1016/0002-9343(68)90049-1 · Cited by 78
Urinary excretion of reduced metabolites of digoxin
Lindenbaum, J., Tse-Eng, D., Butler, V. P., & Rund, D. G. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90260-6 · Cited by 73
Self-citationDIHYDRODIGOXIN: A COMMON METABOLITE OF DIGOXIN IN MAN
CLARK, D. R., & Kalman, S. M. (1974) · Drug Metabolism and Disposition · doi:10.1016/s0022-5347(24)07322-1 · Cited by 65
Arginine, a growth-limiting factor for Eubacterium lentum
Sperry, J. F., & Wilkins, T. D. (1976) · Journal of Bacteriology · doi:10.1128/jb.127.2.780-784.1976 · Cited by 61
Research works printed but not linked: 4
- Clark, D. R., Drug Metab. Dispos. 2: 148 (1974).
- Portius, H. J., Arzneim.-Forsch. (Drug Res.) 14: 1073 (1964).
- Butler, V. P., J. Pharmacol. Exp. Ther. 221: 123 (1982).
- Finegold, S. M., Cancer Res. 35: 3407 (1975).
Cited by
Items 201–287 of 287
Tai, Y.-H., Kao, C., Zhang, Y., Chiou, Y., Chiu, H.-H., Thuy, T. T. D., & Liao, H. (2024) · Talanta · doi:10.1016/j.talanta.2024.127094 · Cited by 4
Understanding and role of gut microbiota on drug response and toxicity
Seshadri, S., Gajjar, D., Joshi, A., Bhatia, Z., & Kumar, S. (2024) · Journal of Toxicological Studies · doi:10.59400/jts.v2i1.1252 · Cited by 4
Distribution of Digoxin-reducing, Oxalate-degrading, and Total Anaerobic Bacteria in the Human Colon
Weaver, G. A., Krause, J. A., Allison, M. J., & Lindenbaum, J. (1992) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v5i5.7853 · Cited by 4
Self-citationNord, C. E., Meurling, L., Russo, R. L., Bello, A., Grasela, D. M., & Gajjar, D. A. (2003) · Journal of Chemotherapy · doi:10.1179/joc.2003.15.3.244 · Cited by 4
Digoxin Disposition in Elderly Humans with Hypochlorhydria
Hui, J., Geraets, D. R., Chandrasekaran, A., Wang, Y. C., Caldwell, J. H., Robertson, L. W., Donnerberg, R. L., & Reuning, R. H. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb02033.x · Cited by 4
Microbiota–Drug Interaction and Its Influence on Drug Metabolism and Toxicity
Pal, R., Bhowmick, P., Mahanty, J., Halder, P., & Bhowmick, M. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_3 · Cited by 3
Mingolelli, G., Subedi, P., Bonitatibus, S., Johnson, J. J., & Henke, M. T. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117199 · Cited by 3
Challenges in Design of Drug Delivery Systems
Murthy, S. N., Shivakumar, H., & Suresh, S. (2021) · Wiley eBooks · doi:10.1002/9781119769644.ch2 · Cited by 3
Pathophysiological and Clinical Potential of Human Microbiome: Microbe-based Therapeutic Insights
Sanyal, S., Nigam, K., Singh, S., Lohani, P., & Dwivedi, M. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010314433240823113111 · Cited by 3
The Promise of Personalized Medicine
Stoll, M. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-79026-8_35 · Cited by 3
Geva‐Zatorsky, N., Elinav, E., & Pettersson, S. (2019) · BioEssays · doi:10.1002/bies.201900002 · Cited by 3
Disposition of Tablet and Capsule Formulations of Digoxin in the Elderly
Hui, J., Wang, Y. C., Chandrasekaran, A., Geraets, D. R., Caldwell, J. H., Robertson, L. W., & Reuning, R. H. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02858.x · Cited by 3
Lipka, E., Crison, J. R., Schug, B. S., Blume, H. H., & Amidon, G. L. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61015-8_2 · Cited by 3
Issues in Contemporary Drug Delivery. Part II: Biopharmaceutical Considerations
Banakar, U. V. (1990) · Journal of Pharmacy Technology · doi:10.1177/875512259000600308 · Cited by 3
The microbiome and cardiovascular disease: Implications in Precision Medicine
Wang, Z., & Osborn, L. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00022-8 · Cited by 3
Human xenobiotic metabolism proteins have full-length and split homologs in the gut microbiome
Rendina, M. C., Turnbaugh, P. J., & Bradley, P. H. (2025) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkaf131 · Cited by 2
Individualizing Pharmacogenomic Test Results in the Context of the Microbiome
Haga, S. B. (2020) · Personalized Medicine · doi:10.2217/pme-2020-0077 · Cited by 2
Inactivation of Digoxin by the Gut Flora and its Reversal by Antibiotics
Dobkin, J. F., & Lindenbaum, J. (1986) · Springer eBooks · doi:10.1007/978-1-4613-8598-1_328 · Cited by 2
Self-citationHutchison, L. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_11 · Cited by 2
Modulation of human microbiome and drug metabolism
Shahid, A., Hayat, S., Munir, S., Ashfaq, U. A., Khan, A. A., Bilal, M., Shaukat, I., & Khurshid, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95120-3.00012-9 · Cited by 2
Yan, A. (2015) · MacSphere (McMaster University) · doi:10.71548/4409 · Cited by 2
The dihydrogenation of digoxin
Lindenbaum, J. (1986) · Steinkopff eBooks · doi:10.1007/978-3-662-11292-2_34 · Cited by 2
Self-citationIntestinal Microbiome and Its Impact on Metabolism and Safety of Drugs
Chu, X. Y., & Ho, P. C. (2023) · Wiley eBooks · doi:10.1002/9781119660699.ch25 · Cited by 1
Ladefoged, L. K., Schiøtt, B., & Fedosova, N. U. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211027 · Cited by 1
Optimizing Pediatric Drug Therapy: Pediatric Pharmacokinetics and Administration Routes
Ngcobo, N. N. (2026) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/jppt-24-00144 · Cited by 1
Harnessing the gut microbiome for precision therapeutics in heart failure
Li, J., Zhang, S., Zhang, Y., 王鑫磊, Zhuge, Y., Wu, Q., Zhao, Y., Gao, Q., Chen, R., Wang, Y., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1781470 · Cited by 1
Eggerthella lenta: metabolism, pathogenesis and therapeutic implications
Rock, R. R., Zhang, S., Noecker, C. A., & Turnbaugh, P. J. (2026) · Nature Reviews Microbiology · doi:10.1038/s41579-026-01344-5 · Cited by 2
Macrolides, Azalides, and Ketolides
Pai, M. P. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-213-7_8 · Cited by 1
Biotransformation by the Gut Microbiome
Chi, L., & Lü, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64268-x · Cited by 1
Галкін, Б. М., & Філіпова, Т. О. (2020) · Microbiology&Biotechnology · doi:10.18524/2307-4663.2020.2(49).211285 · Cited by 1
Pharmaceutical significance and recent developments in utilizing bacterial enzymes
Vulichi, S. R., Kumar, R., Chippada, A. R., Sistla, D. S. M., Chunduri, V. R., Kapur, S., & Galla, K. M. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821406-0.00009-6 · Cited by 1
Macrolides, Azalides, and Ketolides
Pai, M. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-72416-4_2 · Cited by 1
The role of diet and physical activity in influencing the microbiota/microbiome
Murphy, E. A., & Velázquez, K. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822130-3.00017-x · Cited by 1
Lack of Acipimox-Digoxin Interaction in Patient Volunteers
Chijioke, C. P., Pearson, R. M., & Benedetti, S. M. (1992) · Human & Experimental Toxicology · doi:10.1177/096032719201100509 · Cited by 1
Masso, Z. F. (2020) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Dalvie, D., & Testa, B. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc033.pub3 · Cited by 1
STRUCTURE, FUNCTION, AND INHIBITION OF GUT MICROBIAL ENZYMES
Ervin, S. M. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/tkyq-9p77 · Cited by 1
Bifidobacterium , Eubacterium , and Propionibacterium
Wade, W. G., & Downes, J. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0042
The role of efflux and influx transporters in the disposition of digitalis-like compounds
Gozalpour, E. (2015) · Radboud Repository (Radboud University)
Towards in vivo editing of the human microbiome
Yaung, S. J. (2015) · DSpace@MIT (Massachusetts Institute of Technology)
Embree, L. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0098165
Ross, M. C., Ajami, N. J., & Petrosino, J. F. (2016) · ASM Press eBooks · doi:10.1128/9781555819156.ch39
Microbial and human metabolism of cardiac glycosides
Chandrasekaran, A. (1986) · OhioLink ETD Center (Ohio Library and Information Network)
Tzou, M.-C. (1994) · OhioLink ETD Center (Ohio Library and Information Network)
Shepard, T. A. (1983) · OhioLink ETD Center (Ohio Library and Information Network)
Gut microbial-host metabolic interactions following bariatric surgery
Phetcharaburanin, J. (2018) · Spiral (Imperial College London) · doi:10.25560/61845
Mythen, S. M. (2018) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Chemistry and Enzymology Encoded by the Human Microbiome
Shine, E. E., Nwe, P.-K., & Crawford, J. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14659-1
Koppel, N. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Hutchison, L. C. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_11-1
Therapeutic role and importance of gut microbiota in brain and related disorder: A review
Kundu Smita, S., & Rana, D. G. (2021) · Asian Journal of Pharmacy and Pharmacology · doi:10.31024/ajpp.2021.7.1.6
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/01468-6
HUMAN GUT MICROBIOTA AND ITS EFFECTS ON HUMAN HEALTH IN NORMAL AND PATHOLOGICAL CONDITIONS
Munteanu, A. M., Cursaru, R., Guja, L., Carniciu, S., Borcan, A. M., & Popescu‐Spineni, D. (2017) · Romanian Medical Journal · doi:10.37897/rmj.2017.3.2
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53272-5.50005-4
Cotter, P. D., & Barton, W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726708065.793567416
Four-part harmony between diet, drugs, microbes, and host
Bradley, P. H. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.04.013
Microbiome therapeutics as an alternative to the antibiotics
Singh, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00004-5
Basilua, J. M. (2019) · theses.fr (ABES) · doi:10.70675/0af4dbdaz17e6z419czb651z2c72e7aab854
Othman, M. A., Barakat, M. M., Omar, A., Athamneh, T., Zrieq, R. M., Al-Alwany, R. R., & Al‐Najjar, M. A. A. (2024) · Research Square · doi:10.21203/rs.3.rs-4667549/v1
The Epigenetic Impact of the Human Microbiota on Host Cells
Stein, R. A., Cui, R., Faussete, K. C., & Riber, L. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_5
Gut Dysbiosis and Its Potential Impact on Immunomodulation
Ghatak, A. (2023) · International Journal of Bioinformatics and Biological Science · doi:10.30954/2319-5169.1.2023.5
Silva, L. H. A. C., de Sales-Neto, J. M., Soares, M. M., Ferreira, D. A., Medeiros, A. B. A., & Rodrigues‐Mascarenhas, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124132
Gut microbiota impact on drug metabolism, bioavailability, and biotransformation
Boyle, N. R., & Patterson, A. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29289-7.00019-9
Bozzi Cionci, N. (2020) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.48676/unibo/amsdottorato/9158
Letertre, M. P. M. (2019) · Spiral (Imperial College London) · doi:10.25560/89730
Hui, J. (1988) · OhioLink ETD Center (Ohio Library and Information Network)
Les digitaliques : de leur utilisation en cardiologie à leur intérêt potentiel comme anticancéreux
Lafforgue, E. (2024) · HAL
Radojević, D. (2023) · IMAGINE - Repository of the Institute of molecular genetics and genetic engineering (University of Belgrade)
Dinu, L.-D., Vamanu, E., & Avram, I. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_7
Human Gut Bacteria and Food Production Chemicals
Syed, S. (2023) · MacSphere (McMaster University) · doi:10.71548/17070
Masso, Z. F., Mullah, H. B., Thiba, A., Dinat, S., Nweke, E. E., Norton, G. R., Woodiwiss, A. J., Cromarty, D., & Candy, G. P. (2026) · Steroids · doi:10.1016/j.steroids.2026.109747
Smith, L. (2021) · theses.fr (ABES) · doi:10.70675/9f494433z034ez48e9z976cza41f369f247c
Rôle dépendant du sexe du récepteur constitutif aux androstanes CAR dans le métabolisme hépatique
Huillet, M. (2024) · theses.fr (ABES) · doi:10.70675/540eb301z7e1az46b2z8bc9z8e0347fb266a
Saloi, D., Zaman, A., Saha, D., Mehta, P., Das, T., & Das, B. K. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103534
Influence of intestinal Coriobacteriia on host metabolism
Viehof, A. (2025) · RWTH Publications (RWTH Aachen) · doi:10.18154/rwth-2026-04496
Beyond the Bacterial Microbiome: Exploring the Gut Virome and Mycobiome in Health and Disease
Mishra, S. K. (2025) · Current Trends in Biomedical Engineering & Biosciences · doi:10.19080/ctbeb.2025.23.556119
Microbiome: Artifacts in forensic toxicology qualitative and quantitative analysis
Dinis‐Oliveira, R. J., Martins, I. M., Costa, J. G., Freitas, A. R., Remião, F., & Oliveira, N. G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40634-8.00018-0
The microbiota at the interface of environmental toxicants and the brain
Matsuzaki, R., Caudle, W. M., & Sampson, T. R. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.08.002
Composition and Function of the Human Gut Microbiome
Hitch, T. C. A., & Clavel, T. (2026) · Springer eBooks · doi:10.1007/978-3-032-26410-7_2
Dass, A., Bell, K., Rausch, E. P., DeLanoit, Z., & Newman, N. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44037-3.00977-5
Prediction of bacteria-specific drug metabolism using a cross-attention-based model
Park, J. W., Kim, S. E., Yang, H., Cho, N., Kim, H., & Shin, H. K. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag578
Mukherjee, D., Sahu, S., Basu, T., Banerjee, R., Sarkar, S., Maiti, A., Chakraborty, S., & Tarafder, S. (2026) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.5.5.6
Metadata
- Authors
- Dobkin, J. F., Saha, J. R., Butler, V. P., Neu, H. C., & Lindenbaum, J.
- Affiliations
- Harlem Hospital Center (US)
- Columbia University (US)
- ORCID
- Saha, Jnan R.
- Venue
- Science
- Published
- 1983-04-15
- Volume
- 220
- Issue
- 4594
- Pages
- 325-327
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2083212229
- Cited by
- 259
- References
- 15
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 17 · 2023: 16 · 2022: 10 · 2021: 14 · 2020: 29 · 2019: 12 · 2018: 17 · 2017: 10 · 2016: 8 · 2015: 13 · 2014: 8 · 2013: 7 · 2012: 5
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Keywords
- digoxin, bacterial metabolism, Eubacterium lentum, cardiac glycosides, L-arginine, stool culture
- MeSH terms
- Arginine, Colon, Digoxin, Eubacterium, Feces, Humans, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.